T3 Defense
DFNS · NASDAQ
$4.89+$0.13 (+2.73%)TodayMarket closed ·
Prev close $4.76
Who owns DFNS
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 30.8% of DFNS’s shares.
- X S.A. Security and Defense Ltd16.7%
- Shalom (Menachem)6.1%
- VisionWave Holdings Inc4.8%
- X Group Family of Funds Limited Partnership2.4%
- Next 6 largest institutions0.9%
- All other shareholders69.2%
| Holder | Shares | % of shares |
|---|---|---|
| X S.A. Security and Defense Ltd | 168.48K | 16.68% |
| Shalom (Menachem) | 61.47K | 6.09% |
| VisionWave Holdings Inc | 48.00K | 4.75% |
| X Group Family of Funds Limited Partnership | 24.00K | 2.38% |
| UBS Financial Services, Inc. | 4.20K | 0.42% |
| Vanguard Personalized Indexing Management, LLC | 2.70K | 0.27% |
| XTX Markets LLC | 792 | 0.08% |
| UBS Switzerland AG | 770 | 0.08% |
| Clearview Wealth Management LLC | 328 | 0.03% |
| Cygnus Capital Advisors, LLC | 318 | 0.03% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Base Investments Sicav - Macro Dynamic Fund | 10.00K | 0.99% |
| Accelerate Arbitrage Fund | 4.71K | 0.47% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of DFNS in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Shalom Menachem | Other | 2.36M | — |
| Shalom Menachem | Other | 67.01K | — |
| Shalom Menachem | Other | 4.17M | $2.14M |
Short interest
Settled Sep 30, 2026
- Shares short
- 276.27K
- Days to cover
- 1.00
- % of shares outstanding
- 27.35%
- Average daily volume
- 289.84K
- Change since last report
- −19.0%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.